Skip to main content

Aurinia Pharmaceuticals Inc 8-K, filed Oct 30, 2026

Aurinia Pharmaceuticals Inc. (AUPH)

8-K 2026-10-30 For: 2026-10-30
View Original
Added on October 30, 2026

About this 8-K

Aurinia Pharmaceuticals Inc filed this 8-K on October 30, 2026.

Aurinia reported total revenue of $83.7 million for the three months ended September 30, 2026, up 14% from the prior-year period, and raised its 2026 total revenue guidance to $325 million to $330 million. Net income was $31.7 million for the quarter, flat year over year. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits